Brian Joseph Cahill - 28 Feb 2022 Form 4 Insider Report for EAGLE PHARMACEUTICALS, INC. (EGRX)

Role: Chief Financial Officer
Signature: /s/ Brian Cahill
Issuer symbol: EGRX
Transactions as of: 28 Feb 2022
Net transactions value: $0
Form type: 4
Filing time: 02 Mar 2022, 17:09:52 UTC
Previous filing: 04 Feb 2022
Next filing: 21 Dec 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EGRX	Common Stock	Award	$0	+8,000	+32%	$0.000000	32,667	28 Feb 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock upon vesting of the unit. The shares issuable in respect of such RSUs shall vest with respect to 25% of the shares of common stock on each of the one, two, three and four-year anniversaries of February 28, 2022, subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date.

Content

Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock upon vesting of the unit. The shares issuable in respect of such RSUs shall vest with respect to 25% of the shares of common stock on each of the one, two, three and four-year anniversaries of February 28, 2022, subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date.